FDA NDC Directory · JSON-LD · Markdown

HYLENEX Recombinant

NDC 18657-117 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Generic nameHyaluronidase
Labeler / ManufacturerAntares Pharma, Inc.
Marketing categoryBiologic License Application · App BLA021859
Dosage form / routeINJECTION, SOLUTION · SUBCUTANEOUS
Active ingredientsHYALURONIDASE (HUMAN RECOMBINANT) (150 [USP'U]/mL)
Marketing started20051202
Package count1

External sources

Source: openFDA. Public-domain (CC0).